Table 2.
Patient characteristics of the individually matched PTX and non-PTX patients on dialysis at da
| PTX patients (N = 423) | Matched reference patients (N = 1234) | |
|---|---|---|
| Age (years) | ||
| Start of RRT | 51.6 (14.7) | 53.8 (14.4) |
| PTX (d) | 55.2 (13.9) | 56.0 (14.2) |
| Deathb | 64.6 (12.3) | 64.8 (11.9) |
| Sex | ||
| Female | 219 (51.8) | 616 (49.9) |
| Male | 204 (48.2) | 618 (50.1) |
| Time on RRT at PTX (d) (years) | 3.6 (3.2) | 2.2 (2.4) |
| Cause of ESRD | ||
| ADPKD | 68 (14.2) | 173 (14.0) |
| Diabetes mellitus | 64 (15.1) | 192 (15.6) |
| Glomerulonephritis | 122 (28.8) | 363 (29.4) |
| Nephrosclerosis | 46 (10.9) | 132 (10.7) |
| Pyelonephritis | 37 (8.9) | 88 (7.1) |
| Other and unknown | 94 (22.2) | 286 (23.1) |
| First RRT modality | ||
| Haemodialysis | 243 (57.4) | 800 (64.8) |
| Peritoneal dialysis | 172 (40.7) | 424 (34.4) |
| Renal transplant | 8 (1.9) | 10 (0.8) |
| Number of transplants | ||
| 0 | 214 (50.6) | 752 (60.9) |
| 1 | 167 (39.5) | 422 (34.2) |
| 2 | 36 (8.5) | 57 (4.6) |
| 3 | 5 (1.2) | 3 (0.2) |
| 4 | 1 (0.2) | |
| Charlson comorbidity score at PTX (d) | 1.4 (1.7) | 1.6 (1.8) |
| Hospital readmission <30 days from PTX | 127 (30.0) | |
| Alive at end of follow-upc | 233 (55.1) | 604 (49.0) |
| Follow-up time (months from d) | 61.3 (45.7) | 54.6 (43.7) |
Italicized numbers indicate mean (SD); number (%) in plain text.
RRT, renal replacement therapy; ESRD, end-stage renal disease; ADPKD, autosomal dominant polycystic kidney disease.
aThe date of PTX or corresponding time for non-PTX patients.
bIn 190/630 patients, death occurred before end of follow-up, 31 December 2009.
c31 December 2009.